Arizona will receive $2.2 million as its share of a settlement with a drug manufacturer. The attorneys general of Arizona, 47 other states and Washington, D.C., reached settlement with pharmaceutical manufacturer Amgen.
The company was accused of harming consumers by unlawfully promoting its drugs Aranesp and Enbrel and exposing consumers to high costs and serious adverse effects.
The overall settlement was for $71 million.
